down arrow

Dr Lal Pathlabs

  • Market Cap: Large Cap
  • Industry: Hospital & Healthcare Services
  • ISIN: INE600L01024
  • NSEID: LALPATHLAB
  • BSEID: 539524
INR
2,675.45
8.5 (0.32%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 87.92 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Dr Lal Pathlabs Ltd stock-summary
stock-summary
Dr Lal Pathlabs Ltd
Large Cap
Hospital & Healthcare Services
Dr. Lal PathLabs Limited was incorporated as a Private Limited Company with the name `Dr. Lal PathLabs Private Limited', on February 14, 1995 at Delhi. The business of the Partnership Firm, Central Clinical Laboratory was undertaken by the Company. The Company converted into a Public Limited Company and name of the Company was changed to `Dr. Lal PathLabs Limited' vide fresh Certificate of Incorporation granted by the RoC on August 19, 2015.
Company Coordinates stock-summary
Company Details
E-2 Block Sector 18, Rohini New Delhi New Delhi : 110085
stock-summary
Tel: 91-011-3024 4149
stock-summary
cs@lalpathlabs.com
Registrar Details
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 83.57 Cr
Number of Shares
8.36 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
13-Aug-2024
8.36
83.57
93900
10
Issued under ESOP Scheme
17-Nov-2023
8.35
83.48
8000
10
Issued under ESOP Scheme
31-Aug-2023
8.35
83.47
5000
10
Issued under ESOP Scheme
28-Jul-2023
8.35
83.46
49975
10
Issued under ESOP Scheme
13-Jul-2023
8.34
83.41
6000
10
Issued under ESOP Scheme
19-May-2023
8.34
83.41
25000
10
Issued under ESOP Scheme
12-Apr-2023
8.34
83.38
16000
10
Issued under ESOP Scheme
22-Feb-2023
8.34
83.37
14000
10
Issued under ESOP Scheme
03-Jan-2023
8.34
83.35
2000
10
Issued under ESOP Scheme
06-May-2022
8.34
83.35
7000
10
Issued under ESOP Scheme
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 28 Schemes (10.25%)

FIIs

Held by 327 FIIs (26.82%)

Promoter with highest holding

Arvind Lal (30.8%)

Highest Public shareholder

Invesco Oppenheimer International Growth Fund (3.56%)

Individual Investors Holdings

4.01%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
Arvind Lal
Chairman & Exec. Director
2.82 cr
Vandana Lal
Executive Director
2.27 cr
Archana Lal Erdmann
Non Executive Director
14.7 lacs
Om Prakash Manchanda
Executive Director & MD
4.44 cr
Rahul Sharma
Non Executive Director
18.7 lacs
Anoop Mahendra Singh
Independent Director
23.3 lacs
Harneet Singh Chandhoke
Independent Director
18.2 lacs
Sunil Varma
Lead Independent Director
30.8 lacs
Saurabh Srivastava
Independent Director
23.3 lacs
Somya Satsangi
Independent Director
21.3 lacs
Rohit Bhasin
Independent Director
7.7 lacs
Arun Duggal
Independent Director
2.5 lacs
Gurinder Singh Kalra
Independent Non Exe. Director
0
RAJIT MEHTA
Independent Non Exe. Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Cost of Materials Consumed
389.636
0%
 
100
Cost of Materials Consumed
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Service Income
1,164.85
100.00%
Other Operating Revenues
0.05
0.00%
 
100
Service Income
100
Other Operating Revenues
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
597 Cr
(Quarterly Results - Dec 2024)
Net Profit:
97 Cr
stock-summary
Industry

Hospital & Healthcare Services

stock-summary
Market cap

INR 22,365 Cr (Large Cap)

stock-summary
P/E

53.00

stock-summary
Industry P/E

55

stock-summary
Dividend Yield

0.90%

stock-summary
Debt Equity

-0.46

stock-summary
Return on Equity

20.05%

stock-summary
Price to Book

11.14